Consensus Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
732.2 ^USD	-1.81%		-2.47%	+25.61%

Apr. 23	Global markets live: Bayer, PepsiCo, Halliburton, Spotify, Apple...
Apr. 23	Alzheimer's drug adoption in US slowed by doctors' skepticism	RE

Evolution of the average Target Price on Eli Lilly and Company

Price target over the last 5 years

History of analyst recommendation changes

569afcd405d71c83abf2fb4062.eQu6H3FFIsniEXpANuZ7FvSI4efh5fPMOEhl6i5d4mc.KVjXQDQwdZCBQS8wDrchXoz9hKqDnJ6HYi8Iq2ASrDIxO9lzIypQg9J4DQ~42cd8c60da6b547da5baca7e121befc4

Analyst Recommendations on Eli Lilly and Company

Jefferies Raises Eli Lilly's Price Target to $895 From $885, Buy Rating Kept	Apr. 17	MT
BMO Raises Price Target on Eli Lilly to $900 From $865	Apr. 12	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
Goldman Sachs Raises Price Target on Eli Lilly to $723 From $650, Maintains Neutral Rating	Apr. 11	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman...	Apr. 02
Top Midday Stories: Bankman-Fried Gets 25-Year Prison Sentence; Home Depot Acquiring SRS Distribution; Walgreens Lowers FY 2024 Outlook; Analyst Says Short MicroStrategy; Canadian School Boards Sue Social Media Platforms; Eli Lilly Weight-Loss Drug Facing Shortage	Mar. 28	MT
JPMorgan Raises Eli Lilly's Price Target to $850 From $775, Maintains Overweight Rating	Mar. 15	MT
UBS Adjusts Eli Lilly Price Target to $910 From $810, Maintains Buy Rating	Mar. 04	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
BofA Securities Hikes Price Target on Eli Lilly to $1,000 From $800 Citing Tirzepatid Label Expansion, Keeps Buy Rating	Mar. 01	MT
ANALYST RECOMMENDATIONS : Domino's pizza, WPP, PPG, Workday, Eli Lilly...	Feb. 27
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
DZ Bank Downgrades Eli Lilly to Hold From Buy, Raises Price Target to $820 From $790	Feb. 21	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
China move leaves markets unfazed	Feb. 20
Forget about rate cuts...	Feb. 16
Morgan Stanley Raises Price Target on Eli Lilly to $950 From $805, Keeps Overweight Rating	Feb. 16	MT
ANALYST RECOMMENDATIONS : Coinbase, Comcast, Eli Lilly, Nvidia, Uber...	Feb. 15
ELI LILLY AND COMPANY : Jefferies keeps its Buy rating	Feb. 13	ZD
Deutsche Bank Adjusts Eli Lilly and Co. Price Target to $695 From $535, Maintains Hold Rating	Feb. 09	MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow...	Feb. 08
UBS Adjusts Eli Lilly and Co. Price Target to $810 From $710, Maintains Buy Rating	Feb. 07	MT
BofA Securities Raises Price Target on Eli Lilly to $800 From $750, Maintains Buy Rating	Feb. 07	MT
Morgan Stanley Adjusts Price Target on Eli Lilly to $805 From $763, Maintains Overweight Rating	Feb. 07	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

732.2 USD

Average target price

813.3 USD

Spread / Average Target

+11.08%

High Price Target

1,000 USD

Spread / Highest target

+36.57%

Low Price Target

500 USD

Spread / Lowest Target

-31.71%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eli Lilly and Company

Jefferies & Co.
BMO Capital
Goldman Sachs
JPMorgan Chase
UBS
BofA Securities
DZ Bank
Morgan Stanley
JEFFERIES	Akash Tewari
Deutsche Bank Securities
Wolfe Research
Wells Fargo Securities
Cantor Fitzgerald
Morningstar
Truist Securities
Barclays
Guggenheim
Daiwa Securities
Berenberg Bank
Citigroup
Argus
Credit Suisse
HSBC
TD Cowen
SVB Securities LLC
Cowen
Mizuho Securities

Ratings for Eli Lilly and Company

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar